u 69593 has been researched along with ketanserin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dannals, RF; Finley, P; Mathews, WB; Musachio, JL; Ravert, HT; Scheffel, U | 1 |
| Horie, S; Ishihara, S; Minowa, S; Murayama, T; Tsuchiya, S; Watanabe, K | 1 |
2 other study(ies) available for u 69593 and ketanserin
| Article | Year |
|---|---|
[11C]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)-methyl]-1- piperazinecarboxylate ([11C]GR89696): synthesis and in vivo binding to kappa opiate receptors.
Topics: Animals; Benzeneacetamides; Binding, Competitive; Brain; Carbon Radioisotopes; Dopamine Antagonists; Isotope Labeling; Ketanserin; Mice; Piperazines; Pyrrolidines; Radiopharmaceuticals; Receptors, Opioid, kappa; Serotonin Antagonists; Spiperone; Tissue Distribution | 1999 |
Involvement of glutamate and gamma-amino-butyric acid receptor systems on gastric acid secretion induced by activation of kappa-opioid receptors in the central nervous system in rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Baclofen; Benzeneacetamides; Benzomorphans; Bicuculline; Brain; Dynorphins; gamma-Aminobutyric Acid; Gastric Acid; Injections, Intraventricular; Ketanserin; Male; Perfusion; Piperazines; Pyrrolidines; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa; Receptors, Serotonin; Stomach | 2003 |